These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 31927618)
1. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases. Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618 [TBL] [Abstract][Full Text] [Related]
2. Relationship between KRAS mutations and dual time point Mao W; Zhou J; Zhang H; Qiu L; Tan H; Hu Y; Shi H Abdom Radiol (NY); 2019 Jun; 44(6):2059-2066. PubMed ID: 30143816 [TBL] [Abstract][Full Text] [Related]
3. Analyzing the value of delayed 18 F-FDG PET/CT images in diagnosing small colorectal cancer liver metastases in patients with hypothyroidism based on diagnostic accuracy and image standardized uptake value. Pei Y; Wang Z; Hao S; Tong Y; Wu R; Qiao X; Liu Y; Zhang G Nucl Med Commun; 2024 May; 45(5):396-405. PubMed ID: 38372033 [TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
5. Does dual-time-point Wu B; Zhao Y; Zhang Y; Tan H; Shi H Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913 [TBL] [Abstract][Full Text] [Related]
6. Detection of Liver Lesions in Colorectal Cancer Patients Using Boanova LG; Altmayer S; Watte G; Raupp AA; Francisco MZ; De Oliveira GS; Hochhegger B; Andrade RGF Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001662 [TBL] [Abstract][Full Text] [Related]
7. Role of Lopez-Lopez V; Robles R; Brusadin R; López Conesa A; Torres J; Perez Flores D; Navarro JL; Gil PJ; Parrilla P Br J Radiol; 2018 Jan; 91(1081):20170216. PubMed ID: 29034693 [TBL] [Abstract][Full Text] [Related]
8. Role of dual-time point Pang L; Bo X; Wang J; Wang C; Wang Y; Liu G; Yu H; Chen L; Shi H; Liu H Abdom Radiol (NY); 2021 Sep; 46(9):4138-4147. PubMed ID: 33825930 [TBL] [Abstract][Full Text] [Related]
9. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy. Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation. Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846 [TBL] [Abstract][Full Text] [Related]
11. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458 [TBL] [Abstract][Full Text] [Related]
12. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer]. Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291 [TBL] [Abstract][Full Text] [Related]
13. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population. Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346 [TBL] [Abstract][Full Text] [Related]
14. Comparing respiratory gated with delayed scans in the detection of colorectal carcinoma hepatic and pulmonary metastases with 18F-FDG PET-CT. Hassler S; Hubele F; Constantinesco A; Goetz C Clin Nucl Med; 2014 Jan; 39(1):e7-e13. PubMed ID: 23751828 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of dual-time Pahk K; Chung JH; Kim S; Lee SH Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664 [TBL] [Abstract][Full Text] [Related]
17. Value of Wu B; Zhang Y; Tan H; Shi H Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI. Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057 [TBL] [Abstract][Full Text] [Related]
19. PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on Zirakchian Zadeh M Clin Exp Metastasis; 2023 Dec; 40(6):465-491. PubMed ID: 37682423 [TBL] [Abstract][Full Text] [Related]
20. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence. Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]